Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serelaxin in compensated cirrhosis and portal hypertension
NCT01640964Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2013
- Primary completion
- Dec 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of serelaxin in Portal Hypertension (PH), sponsored by Novartis. Started Apr 2013; status: completed.
02
Drugs
serelaxin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT01640964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01640964.